HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China On Verge Of Large-Scale Cosmetics Reg Reforms – PCPC Exec

Executive Summary

The Personal Care Products Council’s head of global strategies says a revised cosmetics framework law could be enacted in China in the 2019 first quarter. It’s expected to shift China to a more risk-based system, reducing bureaucratic red tape and promoting fairer competition, though some of the finer details will depend on implementing regulations.

You may also be interested in...



Cosmetics Industry Awaits ‘Critical’ Safety Assessment Clarification Under China’s New Framework Reg

The China State Council’s January approval of an overarching Cosmetics Supervision and Administration Regulation promises to bring about long-awaited reforms. But draft regulations targeted for release in coming months will be key to the implementation of CSAR provisions, the Personal Care Products Council says.

China May Dispense With Animal-Test Requirements For Imported Non-Special-Use Cosmetics

Reportedly, there would be stipulations for animal-testing waivers, including possession of a Quality Management System certificate, but generally the draft measures should inspire optimism in animal-welfare and industry corners alike.

Avon Joins Global #BeCrueltyFree Campaign Amid Natura Deal Talks

The turnaround-minded direct seller confirmed in late March that it was in discussions with Natura about a potential transaction. Natura prides itself on its cruelty-free status, and Avon increasingly seems like it could be a good fit in that regard.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel